Nordic HTA

Your market access partner from strategy to implementation

Nordic HTA is your Market Access partner

We combine our extensive experience within evidence generation, health economics, market access, and communication to support your market access goals.

Succesful HTA submissions

Our services

  • Value generation strategy
  • Real World evidence
  • Systematic Literature Reviews
  • Statistical Analysis
  • Medical Writing
  • Publication Strategy
  • Early Modelling
  • Cost per Patient
  • Cost-Effectiveness
  • Budget-Impact
  • Payer Engagement Tools
  • Cost Of Illness
  • Value Demonstration Strategy
  • Pricing & Market Access Strategy
  • Value Proposition Development
  • Landscape & Situation Analysis
  • KOL Engagement & Planning
  • Cross-market Reimbursement/HTA submissions
  • Value Dossiers
  • Value Communication Strategy
  • Value Demonstration Tools
  • Effective Sales Implementation & Training
  • Publications

Excellence within

Be ready for the paradigm shift within MedTech HTA!

At Nordic HTA we have a strong team with extensive experience within MedTech HEOR and Market Access. We are your optimal partner for market access support from strategy to implementation.

We have extensive expertise within Orphan drugs and rare diseases HTA support. We are your partner for pragmatic and manageable market access solutions, such as Managed Entry Agreements and supportive Real World Evidence.

Latest news

Do you want to gain insight on market trends? Make sure to read the latest news from Nordic HTA.

New partner in Nordic HTA

We are very pleased to welcome Anders Mærkedahl to Nordic HTA. Prior to joining Nordic HTA, Anders Mærkedahl was the Global head of Health Economics & Market Access at Ambu…

Learnings from Danish Medicines Council

The Danish Medicines Council (DMC) has been a reality since January 2017 and is currently under evaluation. Therefore, it is relevant to analyse whether trends in their decisions can be…